Summary ProHealth Longevity's BPC-157 supplement is presented as a premium option in the growing oral peptide market, featuring a single transparent ingredient at a disclosed 500 mcg dosage using the arginate salt form, triple third-party lab testing with available Certificates of Analysis, and the backing of a company with over 36 years in the supplement industry
Intermittent administration produces inconsistent receptor occupancy, leading to patchy pigmentation and reduced photoprotective efficacy
17 Moreover, other trials as the SUSTAIN-6 trial showed that semaglutide, another GLP-1RA also reduced the risk of MACE by 26% and non-fatal stroke by 39% in patients with T2DM
The side effect profile Across the available preclinical and case-series literature, BPC-157 has a generally clean side-effect profile
High calcium levels can lead to: Kidney stones: calcium deposits that form painful stones Nephrocalcinosis: calcium buildup in the kidney tissue Impaired kidney filtering: leading to reduced function over time Additionally, low calcium is often a sign of kidney issues because damaged kidneys cant properly activate vitamin D a critical step for calcium absorption from food
